Board of Advisors

LSC    New York    ENGAGE & SUPPORT 

Our Board of Advisors, all industry leaders, have made a powerful statement by supporting Life Science Cares and our goal to end poverty in our community. Our Advisors make a personal financial contribution annually to make our mission and model possible.

Our Board of Advisor members also choose to volunteer with their companies and recruit their colleagues to join in this collective effort.

NEW YORK BOARD OF ADVISORS

ABCDEFGHIJKLMNOPQRSTUVWXYZ
Michael Aberman

Michael Aberman

Founder and CEO

Xenimmune Therapeutics, Inc.

Sandip Agarwala

Sandip Agarwala

Managing Director

Blue Owl Capital

Jennifer Bland

Jennifer Bland

CEO

New York Bio

Laurence Blumberg

Laurence Blumberg

Biotechnology Executive

Alexandra Cantley

Alexandra Cantley

Partner

Polaris Partners

Kyle Carver

Kyle Carver

Chief Financial Officer

Evommune

Cara Cassino

Cara Cassino

President

Stony Point Life Sciences Consulting LLC

Kerry Clem

Kerry Clem

CCO

Acorda Therapeutics

Bryan Czyzewski

Bryan Czyzewski

Managing Director

Jefferies

Holly Fleiss

Holly Fleiss

Managing Director

JP Morgan

Zandy Forbes

Zandy Forbes

CEO

MeiraGTx

Martin Friedman

Martin Friedman

Managing Member

Pharmakon Advisors

Anjali Ganguli

Anjali Ganguli

Chief Business Officer

Syndax Pharmaceuticals

Matthew Gline

Matthew Gline

CEO

Roivant Sciences

Div Gupta

Div Gupta

Partner

Cooley LLP

Bill Harvey

Bill Harvey

Executive Vice President

JLL

Laurent Hermouet

Laurent Hermouet

Partner

Athyrium

Ruby Holder

Ruby Holder

CSO

Proteovant Therapeutics

Kristian Humer

Kristian Humer

Chief Financial & Business Officer

Viridian Therapeutics

Darren Jones

Darren Jones

Partner

Baker Tilly

Bj Jones

Bj Jones

Chief Commercial Officer

Biohaven

Patrick Jordan

Patrick Jordan

Chairman

World Orphan Drug Alliance (WODA)

Michael Karmiol

Michael Karmiol

Head of Healthcare Equity Capital Markets

BTIG

Cristina Larkin

Cristina Larkin

CEO

CLC Insights LLC

Matthew Leskowitz

Matthew Leskowitz

Managing Director

Goldman Sachs

Michael Margolis

Michael Margolis

Senior Managing Director

Oppenheimer & Co. Inc.

Evan Markou

Evan Markou

Senior Client Partner

Korn Ferry

Scott Metzner

Scott Metzner

Founder & Principal

Janus Property

Matthew Moore

Matthew Moore

Chief Business Officer

Arcutis Biotherapeutics, Inc.

Scott Morenstein

Scott Morenstein

Managing Director

Blackstone Alternative Asset Management

Frank Nestola

Frank Nestola

Founding Partner

Coefficient Health

Edwin O'Connor

Edwin O'Connor

Partner

Goodwin

Eric Poma

Eric Poma

CEO & CSO

Molecular Templates (MTEM)

Andrea  Rabney

Andrea Rabney

President and CEO

Argot Partners

Nishta Rao

Nishta Rao

Managing Director

First Republic Bank

Alan S. Roemer

Alan S. Roemer

Board Chair & Member

Various Biotechnology Companies

Jeff Rowbottom

Jeff Rowbottom

Partner

Iron Park Capital

Paul J Sekhri

Paul J Sekhri

President & CEO

vTv Therapeutics LLC

Jesse Shefferman

Jesse Shefferman

CEO

Protara Therapeutics, Inc.

Brian Skorney

Brian Skorney

Managing Director

Baird

Lilian Stern

Lilian Stern

Principal

Stern Investor Relations

Arthur Stril

Arthur Stril

Chief Business Officer

Cellectis

Dan Swisher

Dan Swisher

President & Chief Operating Officer

Jazz Pharmaceuticals

Richard Truesdell

Richard Truesdell

Partner

David Polk & Wardwell LLP

Ben van der Schaaf

Ben van der Schaaf

Partner

Arthur D. Little

Brett Zbar

Brett Zbar

Managing Director

General Atlantic